Last edition
News about "Mankind Pharma "
Mankind Pharma, Innovent Biologics to Commercialize Sintilimab for Cancer Care
This strategic collaboration aims to address the critical challenges in cancer treatment and improve patient access to innovative therapeutic options in the region.
Mankind Pharma | 27/12/2024 | By Aishwarya
Mankind Pharma Bags CCI Approval for BSV Acquisition
The proposed transaction involves the acquisition of 100 percent shareholding of Bharat Serums and Vaccines Ltd. (BSV) by Mankind Pharma Ltd.
Mankind Pharma | 10/10/2024 | By Aishwarya
Mankind Pharma to Acquire Bharat Serums and Vaccines
Mankind Pharma has signed a definitive agreement to acquire a 100 percent stake in Bharat Serums and Vaccines Ltd. (BSV) from Advent International, for an enterprise value of approx. INR 13,630 Crores, subject to closing-related adjustments.
Mankind Pharma | 26/07/2024 | By Aishwarya
Mankind Pharma Signs License Deal with Takeda to Commercialise Acidity Drug in India
Mankind Pharma has signed a non-exclusive patent licence agreement with Takeda Pharmaceuticals for commercialising acidity drug Vonoprazan in the Indian market.
Mankind Pharma | 22/07/2024 | By Aishwarya | 121
Mankind Pharma files DRHP with SEBI
The company’s initial public offering comprises an offer for the sale of 40,058,884 equity shares of face value Rs 1
Mankind Pharma | 19/09/2022 | By Sudeep Soparkar | 310
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy